SCHEMBL4691306

SCHEMBL4691306

CC(C)(C)OC(=O)Nc1ccccc1CCCO

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.46
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
TDP1 Q9NUW8 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
CNR2 P34972 1/20 0.41
SLC16A3 O15427 2/20 0.40
BRD9 Q9H8M2 1/20 0.40
DRD2 P14416 1/20 0.40
METAP1 P53582 1/20 0.39
AKT1 P31749 1/20 0.39
BRD4 O60885 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
CTSL P07711 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
ELANE P08246 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14333034 0.96 TDP1 (0.44) TRPV1LMNAPOLBTDP1RXFP1
SCHEMBL1772002 0.91 LMNA (0.47) TRPV1LMNAPOLBRXFP1CNR2
SCHEMBL13980666 0.87 AKT1 (0.44) LMNAPOLBRXFP1CNR2SLC16A3
SCHEMBL6502501 0.86 LMNA (0.43) LMNAPOLBRXFP1CNR2SLC16A3
SCHEMBL10788317 0.86 LMNA (0.43) LMNAPOLBRXFP1CNR2SLC16A3
SCHEMBL5757395 0.85 POLB (0.47) LMNAPOLBRXFP1CNR2BRD9
SCHEMBL646870 0.85 ALDH1A1 (0.50) TRPV1LMNAPOLBRXFP1CNR2
SCHEMBL29729975 0.85 ALDH1A1 (0.50) TRPV1LMNAPOLBRXFP1CNR2
SCHEMBL10785428 0.85 SLC16A3 (0.43) LMNAPOLBRXFP1CNR2SLC16A3
SCHEMBL7236704 0.85 POLB (0.42) LMNAPOLBRXFP1CNR2SLC16A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102859439-B Positive radiation-sensitive composition, display element interlayer dielectric and forming method thereof JSR株式会社 2017-06-30 CN disclosed
CN-102859439-A Positive radiation-sensitive composition, interlayer insulating film for display element, and formation method for same JSR CORP 2013-01-02 CN disclosed
EP-1443046-B1 NOVEL 4-(2FUROYL)AMINOPIPERIDINES, INTERMEDIATES IN SYNTHESIZING THE SAME, PROCESS FOR PRODUCING THE SAME AND MEDICINAL USE OF THE SAME KYORIN SEIYAKU KK (JP) 2008-12-17 EP disclosed
EP-1443046-B1 NOVEL 4-(2FUROYL)AMINOPIPERIDINES, INTERMEDIATES IN SYNTHESIZING THE SAME, PROCESS FOR PRODUCING THE SAME AND MEDICINAL USE OF THE SAME KYORIN SEIYAKU KK (JP) 2008-12-17 EP disclosed
US-20080194826-A1 Novel 4-(2-furoyl) aminopiperidienes, intermediates for synthesizing the same, processes for preparing the same and medicinal use of the same KYORIN PHARMACEUTICAL CO., LTD. 2008-08-14 US disclosed
US-20080194826-A1 Novel 4-(2-furoyl) aminopiperidienes, intermediates for synthesizing the same, processes for preparing the same and medicinal use of the same KYORIN PHARMACEUTICAL CO., LTD. 2008-08-14 US disclosed
US-20080194826-A1 Novel 4-(2-furoyl) aminopiperidienes, intermediates for synthesizing the same, processes for preparing the same and medicinal use of the same KYORIN PHARMACEUTICAL CO., LTD. 2008-08-14 US disclosed
US-7375115-B2 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same KYORIN PHARMACEUTICAL CO., LTD. (JP) 2008-05-20 US disclosed
US-7375115-B2 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same KYORIN PHARMACEUTICAL CO., LTD. (JP) 2008-05-20 US disclosed
US-7375115-B2 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same KYORIN PHARMACEUTICAL CO., LTD. (JP) 2008-05-20 US disclosed
CN-1205220-C Novel cyclosporins CHEM AG C (CH) 2005-06-08 CN disclosed
US-20050085508-A1 Novel 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same KYORIN PHARMACEUTICAL CO., LTD. (JP) 2005-04-21 US disclosed
EP-1443046-A1 NOVEL 4-(2FUROYL)AMINOPIPERIDINES, INTERMEDIATES IN SYNTHESIZING THE SAME, PROCESS FOR PRODUCING THE SAME AND MEDICINAL USE OF THE SAME Kyorin Pharmaceutical Co., Ltd. (JP) 2004-08-04 EP disclosed
CN-1440400-A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides SMITHKLINE BEECHAMP P L C (GB) 2003-09-03 CN disclosed
CN-1305493-A Novel cyclosporins CHEM AG C (CH) 2001-07-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194826-A1 Novel 4-(2-furoyl) aminopiperidienes, intermediates for synthesizing the same, processes for preparing the same and medicinal use of the same CYP4F2, CYP1A2, CYP4B1 TRPV1 2899/4885LMNA 3475/4885POLB 3628/4885
US-20050085508-A1 Novel 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same OPRM1, OPRD1, HRH4 TRPV1 13/4885LMNA 4826/4885POLB 4561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.